ANZCTR National Health Enabling Capabilities Scheme

Ongoing commitment to support the Australian New Zealand Clinical Trials Registry (ANZCTR)

The Minister for Health, Tanya Plibersek, has announced a grant of $2.1 million from the NHMRC to the Australian New Zealand Clinical Trials Registry (ANZCTR).

The registry is located at the NHMRC Clinical Trials Centre, University of Sydney.

The ANZCTR is an online database that provides public information on trials being conducted in Australia, New Zealand and some other countries. Its aims are to maximise patient participation in trials, minimise unnecessary duplication of research and enable a reliable assessment of the trial evidence by ensuring all relevant trials can be included. It also allows policy makers and researchers to identify potential gaps between current trials research activity and health priorities.

The Australasian registry was one of the first World Health Organization-recognised primary registries of clinical trials in the world.

Evidence from clinical trials guides doctors and patients on best medical practice. The ANZCTR, together with other international trials registries, ensure that all relevant evidence can be accessed in determining best practice. The ANZCTR can also help improve the efficiency and value of clinical trials research undertaken in Australia by helping improve trial participation and planning new trials in priority areas.

The new grant will enable the registry to undertake research into the functions of the registry and its use and to make further enhancements so that registry data can be more easily accessed by a variety of users. This will include: better search functionality so trial sites are easier to locate, and more consumer-friendly information, so patients will have easier access to information about current trials.